Trials / Conditions / Chronic Hand Eczema

Chronic Hand Eczema

17 registered clinical trials studyying Chronic Hand Eczema — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refr NCT06283550	Innovaderm Research Inc.	Phase 2
Recruiting	Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers NCT05994976	Innovaderm Research Inc.	—
Unknown	Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) NCT05682859	Jacob Pontoppidan Thyssen	Phase 4
Completed	A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolesc NCT06004050	LEO Pharma	Phase 3
Withdrawn	Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema NCT05545215	Pierre Fabre Medicament	—
Completed	Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema NCT05486117	LEO Pharma	Phase 1
Completed	Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Ha NCT05355818	LEO Pharma	Phase 3
Completed	A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin NCT05259722	LEO Pharma	Phase 3
Completed	Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials NCT04949841	LEO Pharma	Phase 3
Recruiting	Characterization of Chronic Hand Eczema NCT05026554	Dr. Robert Bissonnette	—
Completed	Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) NCT04872101	LEO Pharma	Phase 3
Completed	Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema NCT04871711	LEO Pharma	Phase 3
Completed	Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema NCT04378569	Arcutis Biotherapeutics, Inc.	Phase 1 / Phase 2
Completed	Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids NCT03861455	University Hospital, Toulouse	Phase 2
Completed	Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream NCT03683719	LEO Pharma	Phase 2
Completed	Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan NCT03246776	Beijing Friendship Hospital	Phase 4
Completed	Chronic Hand Eczema - Self-management and Prognosis NCT01482663	University Hospital, Gentofte, Copenhagen	N/A